Crossmark

Modifiable risk factors for permanent pacemaker after transcatheter aortic valve implantation: CONDUCT registry

Crossref DOI link: https://doi.org/10.1136/openhrt-2022-002191

Published Online: 2023-02-07

Published Print: 2023-02

Update policy: https://doi.org/10.1136/crossmarkpolicy

Authors

Rudolph, Tanja

Droppa, Michal https://orcid.org/0000-0001-5807-7615
Baan, Jan

Nielsen, Niels-Erik

Baranowski, Jacek

Hachaturyan, Violetta

Kurucova, Jana

Hack, Luis

Bramlage, Peter

Geisler, Tobias
Clinical Trials ^BETA

Clinical trials referenced in this document:

nct03497611 at ClinicalTrials.gov

Documents that mention this clinical trial

Modifiable risk factors for permanent pacemaker after transcatheter aortic valve implantation: CONDUCT registry
https://doi.org/10.1136/openhrt-2022-002191
Funding

Funding for this research was provided by:

Edwards Lifesciences
License Information

License valid from 2023-02-07